Downgrading GoodRx to a sell rating on recent decline fundamentals. GoodRx's revenue growth is decelerating, with significant reliance on retail partnerships and cyclical transactional revenue, making ...
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on GoodRx Holdings (NASDAQ:GDRX) in the last three months. The following table encapsulates their ...
Prescription savings company GoodRx launched an initiative April 27 in which patients can find, apply for and claim Sanofi discounts directly on GoodRx’s platform. On GoodRx’s website, users can ...
Telemedicine and pharmacy discount company GoodRx on Sept. 23 launched GoodRx Health, an online hub providing research-based answers to health questions. GoodRx Health will provide easily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results